Annual Reports | Financial Reports | Regulatory Information | Invitations | List of Owners | Financial Archive
RLS Global AB (publ) Interim Report, Q2, 2023
RLS Global AB (publ) Interim Report, Q1, 2023
RLS GLOBAL AB (publ) YEAR-END REPORT, Q4, 2022
RLS GLOBAL AB (publ) INTERIM REPORT, Q3, 2022
RLS GLOBAL AB (publ) INTERIM REPORT, Q2, 2022
RLS GLOBAL AB (publ) INTERIM REPORT, Q1, 2022
RLS GLOBAL AB (publ) YEAR-END REPORT, Q4, 2021
RLS GLOBAL AB (publ) INTERIM REPORT Q3 2021
RLS GLOBAL AB (publ) INTERIM REPORT Q2 2021
RLS GLOBAL AB (publ) INTERIM REPORT Q1 2021
RLS GLOBAL AB (publ) YEAR-END REPORT 2020
RLS Global AB (publ), Interim Report Q3, 2020
RLS Global AB (publ), Interim Report Q2, 2020
RLS Global AB (publ), Interim Report Q1, 2020
RLS Global AB (publ) YEAR-END REPORT 2019
RLS Global AB (publ) Interim Report
JANUARY – SEPTEMBER, 2019
RLS Global AB (publ) Interim Report
JANUARY – JUNE, 2019
RLS Global AB (publ) Interim Report Q1 2019
JANUARY – MARCH, 2019
RLS Global AB (publ) Year-end report 2018
Read more
RLS Global is a Swedish MedTech company based in Gothenburg, founded in 1996. Through our advanced and unique Buffered Hypochlorite based Technology Platform we focus on developing products based on Gentle methods for Minimally Invasive Treatment.
RLS Global AB
Neongatan 5
SE 431 53 Mölndal
Sweden
Customer Services & Orders:
+46 31 780 68 20
customer@rlsglobal.com
Office
+46 31 780 68 20
customer@rlsglobal.com
I am text block. Click edit button to change this text. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo. I am text block. Click edit button to change this text. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.
I am text block. Click edit button to change this text. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo. I am text block. Click edit button to change this text. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.
I am text block. Click edit button to change this text. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo. I am text block. Click edit button to change this text. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.
I am text block. Click edit button to change this text. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo. I am text block. Click edit button to change this text. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.
How does it work?
Using ChloraSolv
ChloraSolv consists of two solutions provided in a double syringe. The solutions are mixed to form a gel at the time of use. The gel is applied on the wound bed and allowed to act for 2 minutes to soften the devitalized tissue. A blunt instrument is then used to help in the mechanical removal devitalized tissue from the application site. Finish the procedure with a second application of the gel directly onto the wound area to completely clean the wound bed.
ChloraSolv – a valuable addition in the treatment of infected diabetic foot ulcers providing non-surgical debridement
We use cookies to help us deliver our services and provide personalised experiences. By using this website, you agree to our use of cookies.
